Table 4.
Serial non-demanders n = 88 |
Serial demanders = 659 |
|||
---|---|---|---|---|
Certainty | Coefficient | 95%-CI | Coefficient | 95%-CI |
Disease | ||||
Respiratory disease | ref | ref | ||
Cancer | −0.23 | [-0.73,0.27] | −0.01 | [-0.10,0.08] |
Genital warts | 0.00 | [-0.13,0.12] | −0.04 | [-0.20,0.12] |
Safety | ||||
No side effect | ref | ref | ||
Scientific surveillance | 0.02 | [-0.08,0.13] | −0.15 | [-0.35,0.05] |
Safety other countries | −0.01 | [-0.22,0.20] | −0.81*** | [-1.02,-0.60] |
Benefit/risk | 0.07 | [-0.33,0.47] | −0.93*** | [-1.22,-0.65] |
Indirect Protection | ||||
Protects only you | ref | ref | ||
Protects other people | −0.02 | [-0.41,0.38] | −0.01 | [-0.09,0.07] |
Elimination | 0.09 | [-0.29,0.47] | 0.09 | [-0.03,0.21] |
Coverage | ||||
Not enough | ref | ref | ||
Already a third | 0.11 | [-0.01,0.24] | 0.28*** | [0.14,0.42] |
Most adolescents | 0.07 | [-0.31,0.44] | 0.42*** | [0.33,0.52] |
Other countries 80% | 0.20 | [-0.02,0.42] | 0.33*** | [0.20,0.47] |
***: p-value<0.001. Note: clustered standard errors at the school level.
Note: the dependent variable is choice certainty (0–10).